OPKO Health Inc. (NASDAQ:OPK) Relative Strength Index (RSI) is 38.90, with weekly volatility at 5.56% and ATR at 0.19. The OPK stock’s 52-week price range has touched low of $2.08 and a $6.47 high. Intraday shares traded counted 2.89 million, which was 51.96% higher than its 30-day average trading volume of 6.01M. Its shares traded lower over the last trading session, losing -2.43% on 05/17/21. The shares fell to a low of $3.41 before closing at $3.61. OPK’s previous close was $3.70 while the outstanding shares total 640.85M. The firm has a beta of 1.81, a 12-month trailing P/E ratio of 19.10, and a growth ratio of 1.59.
Investors have identified the Diagnostics & Research company OPKO Health Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $2.23 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
OPKO Health Inc. (OPK) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For OPK, the company has in raw cash 89.5 million on their books with 17.82 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on a decline. In terms of their assets, the company currently has 599.05 million total, with 403.93 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 0.07 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on OPK sounds very interesting.
Is the stock of OPK attractive?
In related news, CEO & Chairman, FROST PHILLIP MD ET AL bought 75,000 shares of the company’s stock in a transaction that recorded on May 10. The purchase was performed at an average price of 3.65, for a total value of 273,745. As the purchase deal closes, the CEO & Chairman, FROST PHILLIP MD ET AL now bought 75,000 shares of the company’s stock, valued at 287,742. Also, CEO & Chairman, FROST PHILLIP MD ET AL bought 25,000 shares of the company’s stock in a deal that was recorded on May 06. The shares were cost at an average price of 3.91 per share, with a total market value of 97,782. Following this completion of disposal, the CEO & Chairman, FROST PHILLIP MD ET AL now holds 25,000 shares of the company’s stock, valued at 98,481. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.50%.